Lucid Group, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Lucid Group, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $595.27M | Feb 27, 2024 |
| FY2023 | Dec 31, 2022 | $608.18M | Feb 27, 2024 |
| FY2023 | Dec 31, 2021 | $27.11M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $3.98M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $4.59M | Feb 28, 2022 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.35B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $807.83M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $595.27M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $608.18M | Feb 25, 2025 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.70B) | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | ($2.71B) | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | ($2.83B) | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | ($1.30B) | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | ($2.58B) | Feb 27, 2024 |
| FY2020 | Dec 31, 2020 | ($63.47M) | May 14, 2021 |
| FY2020 | Sep 30, 2020 | ($54.30M) | May 14, 2021 |
| FY2021 | Dec 31, 2019 | ($277.36M) | Feb 28, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($3.50B) | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | ($3.02B) | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | ($3.10B) | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | ($2.59B) | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | ($1.53B) | Feb 27, 2024 |
| FY2020 | Dec 31, 2020 | ($2.98M) | May 14, 2021 |
| FY2021 | Dec 31, 2019 | ($257.93M) | Feb 28, 2022 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.21B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $1.18B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $937.01M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $821.51M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $750.19M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $511.11M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $220.22M | Feb 28, 2022 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.03B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $900.95M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $797.24M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $734.57M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $652.48M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $89.02M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $38.38M | Feb 28, 2022 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.93B) | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | ($2.02B) | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | ($2.49B) | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | ($2.23B) | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | ($1.06B) | Feb 27, 2024 |
| FY2020 | Dec 31, 2020 | ($2.47M) | May 14, 2021 |
| FY2021 | Dec 31, 2019 | ($235.30M) | Feb 28, 2022 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $868.16M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $883.84M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $910.64M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $1.07B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $421.22M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $459.58M | Feb 28, 2023 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.39B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $9.65B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $8.51B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $7.88B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $7.88B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $1.40B | Feb 28, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.39B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $4.48B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $3.66B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $3.53B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $3.97B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $227.38M | Feb 28, 2022 |
| FY2020 | Sep 30, 2020 | $207.89M | May 14, 2021 |
| FY2020 | Aug 3, 2020 | $155.87M | May 14, 2021 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $717.29M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $3.87B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $4.85B | Feb 24, 2026 |
| FY2025 | Dec 31, 2022 | $4.35B | Feb 24, 2026 |
| FY2024 | Dec 31, 2021 | $3.91B | Feb 25, 2025 |
| FY2023 | Dec 31, 2020 | ($1.32B) | Feb 27, 2024 |
| FY2020 | Sep 30, 2020 | $5.00M | May 14, 2021 |
| FY2020 | Aug 3, 2020 | $5.00M | May 14, 2021 |
| FY2020 | Apr 29, 2020 | $0 | May 14, 2021 |
| FY2022 | Dec 31, 2019 | ($621.08M) | Feb 28, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($15.61B) | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | ($12.91B) | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | ($10.20B) | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | ($7.37B) | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | ($6.07B) | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | ($1.36B) | Feb 28, 2022 |
| FY2020 | Sep 30, 2020 | $54.30M | May 14, 2021 |
| FY2020 | Aug 3, 2020 | $2.17M | May 14, 2021 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $997.83M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $1.61B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $1.37B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $1.74B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $6.26B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $614.41M | Feb 28, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (11) | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | (12) | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | (13) | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | (6) | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | (28) | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | (13) | Feb 28, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (12) | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | (12) | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | (13) | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | (1) | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | (6) | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | (28) | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | (13) | Feb 28, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 327.37M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | 303.14M | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | 2.30B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | 1.83B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | 1.65B | Feb 28, 2023 |
| FY2023 | Jul 23, 2021 | 1.62B | Feb 27, 2024 |
| FY2023 | Jul 22, 2021 | 451.30M | Feb 27, 2024 |
| FY2021 | Dec 31, 2020 | 28.79M | Feb 28, 2022 |